# Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Canonical URL: https://biopharmsignal.com/news/VRAX/virax-biolabs-achieves-iso-certifications-laying-foundation-for-regulated-ivd-development-and-u-s-clinical-validation
Ticker: VRAX
Company: Virax Biolabs
Source: Virax Biolabs
Published: 2026-03-31 11:34 EST
Original Source URL: https://ir.viraxbiolabs.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-16 11:30 EST — [Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement](https://biopharmsignal.com/news/VRAX/virax-biolabs-ceo-james-foster-provides-shareholder-update-following-fiscal-2026-e1b97d68) — Source: Virax Biolabs
- 2026-07-10 20:05 EST — [Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds](https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-closing-of-exercise-of-preferred-investmen-cc034f76) — Source: Virax Biolabs
- 2026-07-09 17:35 EST — [Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds](https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-exercise-of-preferred-investment-options-f-60095931) — Source: Virax Biolabs
- 2026-07-09 11:30 EST — [Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics](https://biopharmsignal.com/news/VRAX/virax-biolabs-signs-multi-country-commercial-supply-agreement-with-fosun-diagnos-d54171ee) — Source: Virax Biolabs
- 2026-06-24 13:00 EST — [Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation](https://biopharmsignal.com/news/VRAX/virax-biolabs-group-limited-announces-1-for-25-share-consolidation-aa5a26d6) — Source: Virax Biolabs
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)